Cargando…
Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes
Loss of stromal caveolin-1 (Cav-1) is a biomarker of a cancer-associated fibroblast (CAF) phenotype and is related to progression, metastasis, and poor outcomes in several cancers. The objective of this study was to evaluate the clinical significance of Cav-1 expression in invasive epithelial ovaria...
Autores principales: | Saeed-Vafa, Daryoush, Marchion, Douglas C., McCarthy, Susan M., Hakam, Ardeshir, Lopez, Alexis, Wenham, Robert M., Apte, Sachin M., Chen, Dung-Tsa, Magliocco, Anthony M., Lancaster, Johnathan M., Reid, Brett M., Permuth, Jennifer B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610269/ https://www.ncbi.nlm.nih.gov/pubmed/34813586 http://dx.doi.org/10.1371/journal.pone.0256615 |
Ejemplares similares
-
Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel
por: CHEN, NING, et al.
Publicado: (2014) -
BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin
por: Bansal, Nisha, et al.
Publicado: (2012) -
BAD-mediated apoptotic pathway is associated with human cancer development
por: STICKLES, XIAOMANG B, et al.
Publicado: (2015) -
A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth
por: MARCHION, DOUGLAS C., et al.
Publicado: (2013) -
In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival
por: Bicaku, E, et al.
Publicado: (2012)